AN2 Therapeutics, Inc. (ANTX)

Market
Nasdaq
Sector
Healthcare
Trend
Strong uptrend
Last close
5.89 (-1.01% on the day)
MA50
5.3
MA200
3.38
52-week range
1.03–6.28
Market cap
209.4M USD
Dividend yield
0%
Data as of
2026-09-04
Quarterly revenue and earnings, millions of USD
QuarterRevenueYoY %EarningsYoY %
Q1 20250-10.7
Q2 20250-6.5
Q3 20250-9.3
Q4 20250-8.7
Q1 20260-10

All markets — KeepWinning global stock screener

Other companies on Nasdaq: Journey Medical Corporation (DERM), Oramed Pharmaceuticals Inc. (ORMP), Coherus Oncology, Inc. (CHRS), First Capital, Inc. (FCAP), PepGen Inc. (PEPG), Eagle Nuclear Energy Corp. (NUCL)